LU91220I2 - Tipranavir ou un de ses sels pharmaceutiques (aptivus) - Google Patents

Tipranavir ou un de ses sels pharmaceutiques (aptivus)

Info

Publication number: LU91220I2
Authority: LU; Luxembourg
Prior art keywords: aptivus; tipranavir; ones; pharmaceutical salt; pyran
Prior art date: 1994-05-06

Application number

LU91220C

Other languages

English (en)

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-06

Filing date

2006-02-08

Publication date

2006-04-10

2006-02-08 Application filed by Upjohn Co filed Critical Upjohn Co

2006-04-10 Publication of LU91220I2 publication Critical patent/LU91220I2/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LU91220C 1994-05-06 2006-02-08 Tipranavir ou un de ses sels pharmaceutiques (aptivus) LU91220I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23881794A	1994-05-06	1994-05-06
US34936194A	1994-12-02	1994-12-02

Publications (1)

Publication Number	Publication Date
LU91220I2 true LU91220I2 (fr)	2006-04-10

Family

ID=26931995

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91220C LU91220I2 (fr)	1994-05-06	2006-02-08	Tipranavir ou un de ses sels pharmaceutiques (aptivus)

Country Status (33)

Country	Link
US (2)	US5852195A (fr)
EP (1)	EP0758327B1 (fr)
JP (1)	JP3883206B2 (fr)
KR (1)	KR100445929B1 (fr)
CN (2)	CN1329378C (fr)
AT (1)	ATE236894T1 (fr)
AU (2)	AU701965B2 (fr)
BR (1)	BR9507615A (fr)
CA (2)	CA2560489C (fr)
CO (1)	CO4810313A1 (fr)
CZ (1)	CZ296515B6 (fr)
DE (2)	DE69530294T2 (fr)
DK (1)	DK0758327T3 (fr)
ES (1)	ES2192201T3 (fr)
FI (1)	FI117387B (fr)
FR (1)	FR05C0047I2 (fr)
HK (2)	HK1066796A1 (fr)
HU (1)	HU228057B1 (fr)
IL (3)	IL129871A (fr)
LU (1)	LU91220I2 (fr)
MX (1)	MX9605391A (fr)
MY (2)	MY127701A (fr)
NL (1)	NL300216I2 (fr)
NO (2)	NO315799B1 (fr)
NZ (1)	NZ285510A (fr)
PE (1)	PE23196A1 (fr)
PL (1)	PL190540B1 (fr)
PT (1)	PT758327E (fr)
RU (1)	RU2139284C1 (fr)
SI (1)	SI0758327T1 (fr)
SK (1)	SK284407B6 (fr)
TW (1)	TW504507B (fr)
WO (1)	WO1995030670A2 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL129871A (en) *	1994-05-06	2003-11-23	Pharmacia & Upjohn Inc	Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5914332A (en)	1995-12-13	1999-06-22	Abbott Laboratories	Retroviral protease inhibiting compounds
EP0909184B1 (fr) *	1996-07-03	2003-09-17	PHARMACIA & UPJOHN COMPANY	Distribution ciblee de medicaments a l'aide de derives de sulfonamides
US5834506A (en) *	1996-11-01	1998-11-10	Warner-Lambert Company	Dihydropyrones with improved antiviral activity
US6232333B1 (en)	1996-11-21	2001-05-15	Abbott Laboratories	Pharmaceutical composition
RU2202346C2 (ru) *	1997-07-29	2003-04-20	Фармация Энд Апджон Компани	Фармацевтическая композиция для кислотных липофильных соединений в форме самоэмульгирующейся композиции
ATE215370T1 (de) *	1997-07-29	2002-04-15	Upjohn Co	Selbstemulgierende formulierung enthaltend lipophile verbindungen
RU2211021C2 (ru) *	1997-07-29	2003-08-27	Фармация Энд Апджон Компани	Фармацевтическая самоэмульгирующая композиция и ее носитель для липофильных фармацевтически активных агентов
ATE266654T1 (de)	1997-09-11	2004-05-15	Upjohn Co	Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran- derivaten
JP3610014B2 (ja)	1999-03-18	2005-01-12	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	不斉水素化のための改良された製法
US6956048B2 (en) *	1999-03-31	2005-10-18	Pharmacia & Upjohn Company	Pharmaceutical emulsions for retroviral protease inhibitors
CZ304118B6 (cs)	2000-01-19	2013-11-06	Abbott Laboratories	Farmaceutická kompozice
US6500963B2 (en)	2001-02-22	2002-12-31	Boehringer Ingelheim Pharma Kg	Process for preparing optically active dihydropyrones
DE10108470A1 (de) *	2001-02-22	2002-09-05	Boehringer Ingelheim Pharma	Verfahren zur Herstellung optisch aktiver Dihydropyrone
GB2401606B (en) *	2002-02-25	2005-08-31	Kudos Pharm Ltd	Pyranones useful as ATM inhibitors
ES2268394T3 (es) *	2002-04-01	2007-03-16	Pfizer Inc.	Inhibidores de piranona y pirandiona de la arn polimerasa dependiente del arn del virus de la hepatitis c.
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8377952B2 (en)	2003-08-28	2013-02-19	Abbott Laboratories	Solid pharmaceutical dosage formulation
US8841326B2 (en)	2004-02-12	2014-09-23	Stc.Unm	Therapeutic curcumin derivatives
IL161586A (en) *	2004-04-22	2015-02-26	Rafael Advanced Defense Sys	Irreplaceable energetic material and reactive shielding that uses it
JP2008519073A (ja) *	2004-11-08	2008-06-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チプラナビル及びエトラビリンの同時投与によるｈｉｖ感染症の治療法
JP2008520672A (ja) *	2004-11-16	2008-06-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チプラナビルとダルナビルの共投与によるｈｉｖ感染症の治療方法
US20060128733A1 (en) *	2004-11-19	2006-06-15	Boehringer Ingelheim International Gmbh	Method for treating HIV infection through co-administration of tipranavir and reverset
WO2006055660A2 (fr) *	2004-11-19	2006-05-26	Boehringer Ingelheim International Gmbh	Traitement de l'infection a vih par co-administration de tipranavir et d'uk-427, 857
US20060135563A1 (en) *	2004-12-01	2006-06-22	Boehringer Ingelheim International Gmbh	Method for treating HIV infection through co-administration of tipranavir and SCH-417690
WO2006060159A1 (fr) *	2004-12-01	2006-06-08	Boehringer Ingelheim International Gmbh	Procede de traitement des infections a vih par administration conjointe de tipranavir et de gw695634
JP2008521898A (ja) *	2004-12-01	2008-06-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チプラナビル及びｇｗ８７３１４０を共に投与することを含むｈｉｖ感染症の治療方法
JP5448854B2 (ja)	2007-03-12	2014-03-19	ウェルズファーゴバンクナショナルアソシエイション	オリゴマー−プロテアーゼ阻害剤複合体
US20090062346A1 (en) *	2007-08-29	2009-03-05	Protia, Llc	Deuterium-enriched tipranavir
WO2009042093A1 (fr) *	2007-09-25	2009-04-02	Merck & Co., Inc.	Inhibiteurs de la protéase du vih
WO2009145814A2 (fr) *	2008-03-10	2009-12-03	Vertex Pharmaceuticals Incorporated	Pyrimidines et pyridines utiles comme inhibiteurs des protéines kinases
WO2009114151A1 (fr)	2008-03-12	2009-09-17	Nektar Therapeutics	Conjugués oligomères-acides aminés et oligomères-atazanavir
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
MX2011006890A (es)	2008-12-23	2011-07-20	Pharmasset Inc	Analogos de nucleosidos.
TW201031675A (en)	2008-12-23	2010-09-01	Pharmasset Inc	Synthesis of purine nucleosides
PT2376088T (pt)	2008-12-23	2017-05-02	Gilead Pharmasset Llc	Fosforamidatos de nucleósidos de 2-amino-purina 6-osubstituída
AU2010254415B2 (en)	2009-05-27	2013-07-04	Merck Sharp & Dohme Corp.	HIV protease inhibitors
JP2012530069A (ja)	2009-06-12	2012-11-29	ネクターセラピューティックス	プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
SI2442809T1 (sl)	2009-06-17	2017-01-31	Vertex Pharmaceuticals Incorporated	Inhibitorji replikacije virusov gripe
KR101466245B1 (ko) *	2010-01-15	2014-12-01	한미사이언스 주식회사	테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
CL2011000716A1 (es)	2010-03-31	2012-04-20	Gilead Pharmasset Llc	Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
US8772332B2 (en) *	2010-09-09	2014-07-08	Richard H. Ebright	Arylpropionyl-alpha-pyrone antibacterial agents
US10800725B2 (en)	2010-09-09	2020-10-13	Richard H. Ebright	Arylpropionyl-triketone antibacterial agents
WO2012037508A2 (fr)	2010-09-17	2012-03-22	Rutgers, The State University Of New Jersey	Agents antibactériens : dérivés de myxopyronine de puissance élevée
US9079834B2 (en)	2010-10-28	2015-07-14	Merck Canada Inc.	HIV protease inhibitors
WO2012083117A1 (fr)	2010-12-16	2012-06-21	Vertex Pharmaceuticals Incorporated	Inhibiteurs de la réplication des virus de la grippe
UA118010C2 (uk)	2011-08-01	2018-11-12	Вертекс Фармасьютікалз Інкорпорейтед	Інгібітори реплікації вірусів грипу
WO2013059928A1 (fr)	2011-10-26	2013-05-02	Merck Canada Inc.	Inhibiteurs de la protéase du vih
US9517994B2 (en)	2012-01-05	2016-12-13	Rutgers, The State University Of New Jersey	Antibacterial agents: phloroglucinol derivatives
AU2013315833A1 (en)	2012-09-11	2015-03-05	Merck Canada Inc.	HIV protease inhibitors
US9227990B2 (en)	2012-10-29	2016-01-05	Cipla Limited	Antiviral phosphonate analogues and process for preparation thereof
WO2015013835A1 (fr)	2013-07-31	2015-02-05	Merck Sharp & Dohme Corp.	Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
MX382171B (es)	2013-11-13	2025-03-13	Vertex Pharmaceuticals Incorporated	Inhibidores de replicacion del virus de influenza.
AU2014348752C1 (en)	2013-11-13	2019-11-21	Vertex Pharmaceuticals Incorporated	Methods of preparing inhibitors of influenza viruses replication
WO2015095276A1 (fr)	2013-12-19	2015-06-25	Merck Sharp & Dohme Corp.	Inhibiteurs de la protéase du vih
EP3083609B1 (fr)	2013-12-19	2018-08-15	Merck Sharp & Dohme Corp.	Inhibiteurs de la protéase du vih
US9994587B2 (en)	2014-03-06	2018-06-12	Merck Sharp & Dohme Corp.	HIV protease inhibitors
WO2015138220A1 (fr)	2014-03-10	2015-09-17	Merck Sharp & Dohme Corp.	Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
US9738664B2 (en)	2014-10-29	2017-08-22	Wisconsin Alumni Research Foundation	Boronic acid inhibitors of HIV protease
WO2016183116A1 (fr)	2015-05-13	2016-11-17	Vertex Pharmaceuticals Incorporated	Procédés de préparation d'inhibiteurs de réplication des virus de la grippe
MA42422A (fr)	2015-05-13	2018-05-23	Vertex Pharma	Inhibiteurs de la réplication des virus de la grippe
WO2017100645A2 (fr)	2015-12-10	2017-06-15	Rutgers, The State University Of New Jersey	Inhibiteurs d'arn polymérase bactérienne : aryl propanoyle, aryl propénoyle et aryl cyclopropane carboxyl phloroglucinols
WO2017156458A1 (fr)	2016-03-11	2017-09-14	University Of South Florida	Inhibiteurs de bêta-lactamases, formulations et utilisations correspondantes
US11993590B2 (en) *	2016-12-04	2024-05-28	712 North Inc.	Pyranone compounds useful to modulate OMA1 protease
WO2019160875A1 (fr)	2018-02-13	2019-08-22	Rutgers, The State University Of New Jersey	Agents antibactériens : sels solubles et formulations aqueuses de pyronines
WO2019160873A1 (fr)	2018-02-13	2019-08-22	Rutgers, The State University Of New Jersey	Agents antibactériens : pyronines o-alkyl-deutérés
US11572337B2 (en)	2018-03-06	2023-02-07	Rutgers, The State University Of New Jersey	Antibacterial agents: arylalkylcarboxamido phloroglucinols
CN110551090B (zh) *	2019-10-21	2021-06-18	扬州工业职业技术学院	一种超声波提取中药狗脊中抗肿瘤活性成分的方法
US20230218644A1 (en)	2020-04-16	2023-07-13	Som Innovation Biotech, S.A.	Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2024130166A2 (fr) *	2022-12-16	2024-06-20	Denali Therapeutics Inc.	Composés, compositions et méthodes

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB193507A (en)	1921-11-25	1923-02-26	English Electric Co Ltd	Improvements in and connected with hydraulic impulse turbines
NL80964C (fr) *	1952-03-08
NL83407C (fr) *	1952-05-16
US2723277A (en) *	1952-08-26	1955-11-08	Hoffmann La Roche	Malonic acid derivatives and process for the manufacture thereof
US2872457A (en) *	1956-04-19	1959-02-03	Wisconsin Alumni Res Found	Process for the preparation of 4-hydroxycoumarin derivatives
GB836740A (en) *	1956-04-25	1960-06-09	Bayer Ag	Coumarin derivatives and their production
FR1276654A (fr) *	1958-10-01	1961-11-24		Nouveaux dérivés de l'hydroxy-4-alpha-2-pyrone
FR1463767A (fr) *	1963-04-03	1966-07-22	Clin Byla Ets	Dérivés de la coumarine et leur préparation
BE674997A (fr) *	1965-01-13	1966-07-12
FR1559595A (fr) *	1966-12-13	1969-03-14
US3489774A (en) *	1967-04-24	1970-01-13	Dow Chemical Co	3-(beta-aryl-beta-(arylthio) (or arylseleno) propionyl)-coumarin products
US3493586A (en) *	1969-01-23	1970-02-03	Dow Chemical Co	3-(beta-aryl-beta-(arylthio) (or arylseleno)-propionyl)pyrone products
JPS4823942B1 (fr) *	1969-02-14	1973-07-17
US3764693A (en) *	1969-11-21	1973-10-09	Lipha	A rodenticidal compositions containing 4-hydroxy coumarins
US3835161A (en) *	1972-10-24	1974-09-10	Realisations Scient S E Res C	3-substituted-4-hydroxy-coumarins
JPS53147073A (en) *	1977-05-24	1978-12-21	Sankyo Co Ltd	Mevalonolactone derivatives
NZ194557A (en) *	1979-08-17	1984-09-28	Merck & Co Inc	Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
CA1171424A (fr) *	1981-06-17	1984-07-24	Alvin K. Willard	( )-(4r, 6s) - (e)-6-[2-(4'fluoro-3,3', 5-trimethyl- [1,1'-biphenyle]-2-yl)ethenyle]-3,4,5,6- tetrahydro-4-hydroxy-2h-pyran-2-one
JPS634652A (ja) *	1986-06-25	1988-01-09	Hitachi Ltd	半導体装置
AU1044088A (en)	1986-12-17	1988-07-15	Nippon Soda Co., Ltd.	Heterocyclic compounds having triketo skeleton
US4900754A (en) *	1987-12-21	1990-02-13	Rorer Pharmaceutical Corp.	HMG-COA reductase inhibitors
EP0403535A1 (fr) *	1988-03-01	1990-12-27	The Upjohn Company	Coumarines permettant d'inhiber la transcriptase inverse chez les etres humains
DE3929913A1 (de) *	1989-09-08	1991-04-04	Hoechst Ag	4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
EP0494231A4 (en) *	1989-09-26	1992-09-16	The Regents Of The University Of California	6-amino-1,2-benzopyrones useful for treatment of viral diseases
CA2066644A1 (fr) *	1989-10-27	1991-04-28	Robert L. Heinrikson	Methode de traitement du vih et d'autres retrovirus et composes utilises pour ce faire
JPH03227923A (ja)	1990-01-30	1991-10-08	Sawai Seiyaku Kk	ひと免疫不全ウイルス疾患処置剤
SE9000624D0 (sv) *	1990-02-22	1990-02-22	Pharmacia Ab	New use
CA2035972C (fr) *	1990-02-23	2006-07-11	Martin Karpf	Procede de preparation d'oxetanones
AU8612491A (en) *	1990-09-07	1992-03-30	Schering Corporation	Antiviral compounds
AU8448491A (en) *	1990-09-07	1992-03-30	Schering Corporation	Antiviral compounds and antihypertensive compounds
JPH07110853B2 (ja) *	1990-09-07	1995-11-29	シェリング・コーポレーション	抗ウイルス化合物および抗高血圧化合物
US5484951A (en) *	1990-10-19	1996-01-16	Octamer, Incorporated	5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
EP0578745A1 (fr) *	1991-04-04	1994-01-19	The Upjohn Company	Composes contenant du phosphore et servant d'inhibiteurs de retrovirus
AU2871592A (en) *	1991-10-11	1993-05-03	Du Pont Merck Pharmaceutical Company, The	Cyclic ureas and analogues useful as retroviral protease inhibitiors
JP3070767B2 (ja) *	1991-10-22	2000-07-31	オクタマー，インコーポレイティド	抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物
DE4308451A1 (de) *	1992-09-10	1994-04-14	Bayer Ag	3-Aryl-pyron-Derivate
ZA938019B (en) *	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) *	1993-02-05	1994-04-12	Opjohn Company	4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IL129871A (en) *	1994-05-06	2003-11-23	Pharmacia & Upjohn Inc	Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

1995
- 1995-05-01 IL IL12987195A patent/IL129871A/xx not_active IP Right Cessation
- 1995-05-04 HU HU9603074A patent/HU228057B1/hu active Protection Beyond IP Right Term
- 1995-05-04 PT PT95918864T patent/PT758327E/pt unknown
- 1995-05-04 CZ CZ0317296A patent/CZ296515B6/cs not_active IP Right Cessation
- 1995-05-04 MX MX9605391A patent/MX9605391A/es active IP Right Grant
- 1995-05-04 SK SK1384-96A patent/SK284407B6/sk not_active IP Right Cessation
- 1995-05-04 CN CNB2004100346805A patent/CN1329378C/zh not_active Expired - Lifetime
- 1995-05-04 AU AU24626/95A patent/AU701965B2/en not_active Expired
- 1995-05-04 DE DE69530294T patent/DE69530294T2/de not_active Expired - Lifetime
- 1995-05-04 TW TW084104473A patent/TW504507B/zh not_active IP Right Cessation
- 1995-05-04 CA CA002560489A patent/CA2560489C/fr not_active Expired - Lifetime
- 1995-05-04 DE DE1995630294 patent/DE122006000014I2/de active Active
- 1995-05-04 SI SI9530660T patent/SI0758327T1/xx unknown
- 1995-05-04 RU RU96123286A patent/RU2139284C1/ru active
- 1995-05-04 JP JP52901695A patent/JP3883206B2/ja not_active Expired - Lifetime
- 1995-05-04 ES ES95918864T patent/ES2192201T3/es not_active Expired - Lifetime
- 1995-05-04 CN CNB951935534A patent/CN1154642C/zh not_active Expired - Lifetime
- 1995-05-04 KR KR1019960706245A patent/KR100445929B1/ko not_active IP Right Cessation
- 1995-05-04 CA CA002187523A patent/CA2187523C/fr not_active Expired - Lifetime
- 1995-05-04 EP EP95918864A patent/EP0758327B1/fr not_active Expired - Lifetime
- 1995-05-04 BR BR9507615A patent/BR9507615A/pt active Search and Examination
- 1995-05-04 PL PL95317061A patent/PL190540B1/pl unknown
- 1995-05-04 NZ NZ285510A patent/NZ285510A/en not_active IP Right Cessation
- 1995-05-04 AT AT95918864T patent/ATE236894T1/de active
- 1995-05-04 US US08/809,224 patent/US5852195A/en not_active Expired - Lifetime
- 1995-05-04 WO PCT/US1995/005219 patent/WO1995030670A2/fr active IP Right Grant
- 1995-05-04 DK DK95918864T patent/DK0758327T3/da active
- 1995-05-05 MY MYPI95001195A patent/MY127701A/en unknown
- 1995-05-05 CO CO95018810A patent/CO4810313A1/es unknown
- 1995-05-05 MY MYPI20051072A patent/MY149862A/en unknown
- 1995-05-08 PE PE1995268036A patent/PE23196A1/es not_active IP Right Cessation
1996
- 1996-05-01 IL IL11356796A patent/IL113567A/xx not_active IP Right Cessation
- 1996-11-05 NO NO19964676A patent/NO315799B1/no not_active IP Right Cessation
- 1996-11-05 FI FI964441A patent/FI117387B/fi not_active IP Right Cessation
1998
- 1998-11-09 US US09/188,998 patent/US6169181B1/en not_active Expired - Lifetime
1999
- 1999-04-09 AU AU23686/99A patent/AU718117B2/en not_active Expired
- 1999-05-10 IL IL12987199A patent/IL129871A0/xx unknown
2004
- 2004-12-07 HK HK04109663A patent/HK1066796A1/xx not_active IP Right Cessation
2005
- 2005-12-22 FR FR05C0047C patent/FR05C0047I2/fr active Active
2006
- 2006-01-20 NL NL300216C patent/NL300216I2/nl unknown
- 2006-02-08 LU LU91220C patent/LU91220I2/fr unknown
- 2006-03-02 NO NO2006003C patent/NO2006003I2/no unknown
- 2006-04-25 HK HK06104885.4A patent/HK1084667A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9603074D0 (en)	1997-01-28
AU718117B2 (en)	2000-04-06
KR100445929B1 (ko)	2005-09-30
IL129871A0 (en)	2000-02-29
CN1150424A (zh)	1997-05-21
HK1066796A1 (en)	2005-04-01
MY127701A (en)	2006-12-29
CA2560489A1 (fr)	1995-11-16
MY149862A (en)	2013-10-31
NO2006003I1 (no)	2006-03-13
ATE236894T1 (de)	2003-04-15
PL317061A1 (en)	1997-03-03
PT758327E (pt)	2003-08-29
FR05C0047I2 (fr)	2007-10-19
SI0758327T1 (en)	2003-08-31
DE122006000014I1 (de)	2006-11-16
NZ285510A (en)	1998-03-25
EP0758327A1 (fr)	1997-02-19
HK1084667A1 (en)	2006-08-04
CZ317296A3 (en)	1997-04-16
NO964676L (no)	1997-01-06
DE122006000014I2 (de)	2007-03-29
NL300216I1 (nl)	2006-04-03
US5852195A (en)	1998-12-22
AU2368699A (en)	1999-06-03
KR970702858A (ko)	1997-06-10
WO1995030670A3 (fr)	1996-04-25
AU701965B2 (en)	1999-02-11
BR9507615A (pt)	1997-09-09
DK0758327T3 (da)	2003-07-28
MX9605391A (es)	1997-12-31
JP3883206B2 (ja)	2007-02-21
SK138496A3 (en)	1997-06-04
HU228057B1 (en)	2012-09-28
RU2139284C1 (ru)	1999-10-10
PE23196A1 (es)	1996-06-07
PL190540B1 (pl)	2005-12-30
CN1329378C (zh)	2007-08-01
CA2187523A1 (fr)	1995-11-16
NO2006003I2 (no)	2008-10-20
FI117387B (fi)	2006-09-29
DE69530294T2 (de)	2003-12-24
CA2560489C (fr)	2010-01-12
IL113567A (en)	2003-05-29
NL300216I2 (nl)	2006-06-01
CN1154642C (zh)	2004-06-23
AU2462695A (en)	1995-11-29
FR05C0047I1 (fr)	2006-03-10
US6169181B1 (en)	2001-01-02
WO1995030670A2 (fr)	1995-11-16
DE69530294D1 (de)	2003-05-15
IL129871A (en)	2003-11-23
NO315799B1 (no)	2003-10-27
CN1539825A (zh)	2004-10-27
ES2192201T3 (es)	2003-10-01
CO4810313A1 (es)	1999-06-30
CA2187523C (fr)	2006-11-21
CZ296515B6 (cs)	2006-04-12
FI964441A0 (fi)	1996-11-05
EP0758327B1 (fr)	2003-04-09
TW504507B (en)	2002-10-01
HUT77601A (hu)	1998-06-29
JPH09512821A (ja)	1997-12-22
FI964441L (fi)	1996-11-05
SK284407B6 (sk)	2005-03-04
NO964676D0 (no)	1996-11-05

Publication	Publication Date	Title
LU91220I2 (fr)	2006-04-10	Tipranavir ou un de ses sels pharmaceutiques (aptivus)
MY119031A (en)	2005-03-31	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
ATE200669T1 (de)	2001-05-15	4-hydroxy-benzopyran-2-one und 4-hydroxy- zykloalkyl(b) - pyran--2-one verwendbarfuer die behandlung von retroviralen infectionen
TR199700844T1 (xx)	1998-01-21	Pirazolil-Benzoil T�revleri.
AU603525B2 (en)	1990-11-15	Tetrazole intermediates to antihypertensive compounds
DE69637380D1 (en)	2008-02-07	Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
TR200800474T2 (tr)	2008-04-21	Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
TR199900163T2 (xx)	1999-04-21	Anti-hiperkolesterinemikler olarak ikameli piridinler ve bifeniller.
ATE196913T1 (de)	2000-10-15	Neuartige peptidderivate
FR2380266A1 (fr)	1978-09-08	Molybdates d'amines heterocycliques, procede d'obtention et application
ATE189894T1 (de)	2000-03-15	Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
FI910366A0 (fi)	1991-01-24	Menetelmä deoksimulundokandiinin valmistamiseksi
BR9508521A (pt)	1997-10-28	Inibição da biossintese de leucotrienos com derivados de uréia
PT1097145E (pt)	2003-10-31	Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
SU666804A1 (ru)	1998-07-10	S-метилсульфониевые соли 3,5-дифенил-2-тиабицикло[4,4,0] декана или дец-5-ена, проявляющие антимикробную активность